Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine infusion and NT-proBNP in femoral shaft fracture surgery
IRCT201511279593N2Phase 3Completed
- Sponsor
- ُShahid Beheshti University of Medical Sciences
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in Femoral diaphyseal fracture, sponsored by ُShahid Beheshti University of Medical Sciences. Primary endpoint: N-terminal pro-B-type natriuretic peptide level. Started Sep 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Femoral diaphyseal fracture
Beyond the preview
Go deeper on IRCT201511279593N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201511279593N2.